PLIN2 and nonpapillary renal cell carcinoma: Both the TPA and datamining results indicated that perilipin-2 (PLIN2) was a potential biomarker to distinguish ccRCC from pRCC, chRCC, and RO (Fig. 2C and Fig. 3A).